Figure 3.
Estimated 5-year Relative Survival Following Initiation of Second-Line Treatment in the Mayo Validation Cohort, Stratified by Fluorescence In Situ Hybridization and IGHV Mutation Status
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.